$0.99
1.83% yesterday
Nasdaq, Nov 15, 10:16 pm CET
ISIN
US75120L1008
Symbol
RLYB

Rallybio Corp Target price 2024 - Analyst rating & recommendation

Rallybio Corp Classifications & Recommendation:

Buy
83%
Hold
17%

Rallybio Corp Price Target

Target Price $8.50
Price $0.99
Potential
Number of Estimates 4
4 Analysts have issued a price target Rallybio Corp 2025 . The average Rallybio Corp target price is $8.50. This is higher than the current stock price. The highest price target is
$13.00 1,211.14%
register free of charge
, the lowest is .
A rating was issued by 6 analysts: 5 Analysts recommend Rallybio Corp to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Rallybio Corp stock has an average upside potential 2025 of . Most analysts recommend the Rallybio Corp stock at Purchase.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Million $ 0.00 0.48

5 Analysts have issued a sales forecast Rallybio Corp 2024 . The average Rallybio Corp sales estimate is

$479k
Unlock
. This is
20.17% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$897k 49.50%
Unlock
, the lowest is
$0.0 100.00%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 $0.0
2025
$229k 52.23%
Unlock
2026
$0.0 100.00%
Unlock
2028
$388m 341.52%
Unlock

1 Analyst has issued an EBITDA forecast Rallybio Corp 2024 . The average Rallybio Corp EBITDA estimate is

$-69.0m
Unlock
. This is
1.23% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-69.0m 1.23%
Unlock
, the lowest is
$-69.0m 1.23%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 $-78.8m 16.33%
2024
$-69.0m 12.41%
Unlock
2025
$-62.0m 10.14%
Unlock
2026
$-45.0m 27.42%
Unlock

EBITDA Margin

2025
-27,103.83% 88.16%
Unlock

2 Rallybio Corp Analysts have issued a net profit forecast 2024. The average Rallybio Corp net profit estimate is

$-53.5m
Unlock
. This is
18.87% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-52.3m 20.75%
Unlock
, the lowest is
$-54.8m 16.98%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 $-76.3m 11.96%
2024
$-53.5m 29.89%
Unlock
2025
$-35.7m 33.33%
Unlock
2026
$-31.1m 12.78%
Unlock
2027
$7.9m 125.32%
Unlock
2028
$193m 2,343.02%
Unlock

Net Margin

2025
-15,598.43% 39.60%
Unlock
2028
49.60% 452.95%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share $ -1.84 -1.29
11.96% 29.89%
P/E negative
EV/Sales negative

2 Analysts have issued a Rallybio Corp forecast for earnings per share. The average Rallybio Corp <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

$-1.29
Unlock
. This is
18.87% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
$-1.26 20.75%
Unlock
, the lowest is
$-1.32 16.98%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 $-1.84 11.96%
2024
$-1.29 29.89%
Unlock
2025
$-0.86 33.33%
Unlock
2026
$-0.75 12.79%
Unlock
2027
$0.19 125.33%
Unlock
2028
$4.64 2,342.11%
Unlock

P/E ratio

Current -0.62 61.01%
2024
-0.77 24.19%
Unlock
2025
-1.15 49.35%
Unlock
2026
-1.32 14.78%
Unlock
2027
5.22 495.45%
Unlock
2028
0.21 95.98%
Unlock

Based on analysts' sales estimates for 2024, the Rallybio Corp stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

-70.50
Unlock
and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of
85.89
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current -56.28
2024
-70.50 25.27%
Unlock
2025
-147.63 109.40%
Unlock
2028
-0.09 77.36%
Unlock

P/S ratio

Current
2024
85.89 25.26%
Unlock
2025
179.85 109.40%
Unlock
2028
0.11 77.35%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today